Loading…
JK Agri Genetics (BSE 536493)₹269.50+10.41%Other Agricultural Products
In the Jun 2026 quarter (standalone), JK Agri Genetics reported sales of ₹83.97 Cr, down 8.7% from Jun 2025, and net profit of ₹11.01 Cr, down 8.3% year on year. For the year to Mar 2026, sales were ₹158 Cr and net profit −₹7.01 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.01 | 22.99 | 36.02 | 79.07 | 29.02 | 26.02 | 28.01 | 91.98 | 19.01 | 23.99 | 23.01 | 83.97 |
| Expenses | 22.95 | 29.97 | 49.89 | 64.91 | 45.89 | 31.93 | 27.97 | 73.85 | 25.97 | 30.98 | 23.95 | 68.88 |
| Operating Profit | −12.98 | −6.99 | −13.99 | 13.99 | −17.01 | −5.99 | −1.01 | 17.99 | −6.99 | −7.99 | −0.99 | 14.99 |
| OPM % | −142.1% | −31.1% | −40.1% | 18.0% | −58.1% | −24.1% | −3.0% | 18.9% | −34.0% | −32.1% | −5.0% | 17.9% |
| Other Income | 1.01 | 1.01 | 5.02 | 1.01 | 1.01 | 14.06 | 2.01 | 2.01 | 1.01 | 2.01 | 1.01 | 1.01 |
| Interest | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Profit before tax | −14.95 | −8.96 | −12.95 | 11.95 | −18.91 | 4.98 | −0.99 | 17.94 | −7.97 | −6.97 | −2.99 | 14.93 |
| Tax % | −29.0% | −29.0% | −31.0% | 30.0% | −29.0% | 26.0% | 79.0% | 31.0% | −33.0% | −28.0% | 251.0% | 29.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.18 | 0.00 | 0.00 | 0.00 | −0.84 | 0.00 | 0.00 |
| Net Profit | −11.02 | −7.01 | −9.01 | 9.01 | −13.01 | 4.01 | −1.01 | 12.01 | −5.01 | −5.01 | −9.01 | 11.01 |
| EPS (Rs) | −23.70 | −14.03 | −18.84 | 18.49 | −28.72 | 7.71 | −2.90 | 26.49 | −10.97 | −11.35 | −19.60 | 23.41 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 186 | 191 | 202 | 191 | 180 | 224 | 246 | 201 | 148 | 162 | 158 | 150 |
| Expenses | 163 | 165 | 175 | 174 | 184 | 203 | 231 | 209 | 173 | 172 | 155 | 150 |
| Operating Profit | 22.99 | 25.99 | 27.01 | 17.01 | −3.99 | 20.99 | 14.99 | −7.99 | −24.99 | −10.01 | 1.99 | −0.98 |
| OPM % | 11.9% | 13.9% | 12.9% | 8.9% | −2.3% | 8.9% | 6.0% | −4.1% | −17.1% | −6.0% | 1.6% | −0.7% |
| Other Income | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | −1.01 | 4.02 | 3.01 | 7.03 | 18.07 | 6.03 | 5.04 |
| Interest | 11.04 | 8.03 | 8.03 | 10.03 | 9.03 | 6.02 | 6.01 | 7.02 | 8.03 | 6.02 | 5.01 | 4.04 |
| Depreciation | 3.99 | 2.99 | 2.99 | 1.99 | 3.99 | 3.99 | 2.99 | 1.99 | 2.99 | 3.99 | 3.99 | 3.96 |
| Profit before tax | 8.96 | 15.93 | 16.93 | 5.98 | −15.95 | 9.95 | 9.96 | −14.95 | −29.89 | −1.99 | 0.00 | −3.00 |
| Tax % | 12.0% | 25.0% | 28.0% | 11.0% | −34.0% | 28.0% | 25.0% | −29.0% | −30.0% | 2.0% | 2,858.0% | — |
| Exceptional items | 0.00 | 0.00 | −0.01 | −0.04 | −0.13 | −1.59 | 0.00 | −0.04 | −0.24 | 12.35 | 1.20 | −0.84 |
| Net Profit | 8.01 | 12.01 | 12.02 | 5.01 | −11.01 | 7.01 | 8.01 | −11.01 | −21.03 | −2.01 | −7.01 | −8.02 |
| EPS (Rs) | 22.24 | 33.78 | 33.26 | 13.80 | −25.86 | 15.44 | 16.65 | −23.28 | −44.88 | −5.38 | −15.45 | −18.51 |
| Dividend payout % | 13.0% | 12.0% | 12.0% | 11.0% | 0.0% | 10.0% | 9.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.99 | 3.99 | 3.99 | 3.99 | 4.00 | 3.99 | 5.00 | 4.98 | 5.00 | 4.99 | 5.01 | 4.99 |
| Reserves | 53.85 | 60.79 | 72.78 | 82.74 | 85.85 | 107 | 131 | 137 | 126 | 105 | 103 | 95.99 |
| Borrowings | 57.90 | 57.80 | 35.90 | 45.87 | 54.91 | 36.88 | 25.97 | 31.95 | 40.03 | 32.03 | 3.01 | 0.00 |
| Other Liabilities | 119 | 122 | 161 | 168 | 118 | 109 | 146 | 170 | 159 | 162 | 187 | 172 |
| Total Liabilities | 235 | 245 | 272 | 301 | 263 | 257 | 307 | 344 | 330 | 304 | 297 | 272 |
| Fixed Assets | 29.90 | 26.90 | 37.86 | 35.86 | 33.89 | 35.85 | 32.87 | 30.89 | 28.88 | 31.86 | 18.92 | 21.91 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.01 | 17.03 | 18.04 | 7.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.02 | 19.02 | 51.08 | 57.07 | 98.04 | 73.08 |
| Other Assets | 204 | 218 | 235 | 265 | 229 | 222 | 251 | 294 | 240 | 199 | 162 | 170 |
| Inventories | 97.02 | 97.98 | 112 | 134 | 131 | 99.88 | 125 | 136 | 137 | 106 | 71.92 | 97.98 |
| Trade receivables | 84.89 | 81.85 | 90.87 | 108 | 72.87 | 64.96 | 76.95 | 104 | 69.96 | 51.94 | 41.95 | 37.94 |
| Cash & equivalents | 3.01 | 4.01 | 5.01 | 5.01 | 5.01 | 32.04 | 27.04 | 31.07 | 5.01 | 5.01 | 6.01 | 1.01 |
| Total Assets | 235 | 245 | 272 | 301 | 263 | 257 | 307 | 344 | 330 | 304 | 297 | 272 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −4.98 | 12.96 | 33.90 | 0.00 | 1.99 | 24.94 | 20.95 | −0.99 | 12.96 | 36.91 | 2.99 | −27.91 |
| Cash from investing activity | −0.99 | 0.99 | −1.99 | −0.99 | 0.00 | 0.00 | −21.98 | 4.99 | −39.96 | −14.99 | 31.95 | 29.99 |
| Cash from financing activity | −4.98 | −11.95 | −30.86 | 0.99 | −1.99 | 0.99 | −3.99 | −0.99 | 0.99 | −21.93 | −33.87 | −6.97 |
| Net cash flow | −9.97 | 0.99 | 0.99 | −0.99 | 0.00 | 26.94 | −4.99 | 3.99 | −25.94 | −0.99 | 0.99 | −4.99 |
| Capex | 1.26 | 0.98 | 3.04 | 1.76 | 0.97 | 0.33 | 1.22 | 0.84 | 11.40 | 13.35 | 4.34 | 0.71 |
| Free cash flow | −6.02 | 12.04 | 31.11 | −2.01 | 2.01 | 25.08 | 20.07 | −2.01 | 2.01 | 24.07 | 72.21 | −29.12 |
| CFO / OP % | −3.0% | 67.0% | 144.0% | 12.0% | 24.0% | −622.0% | 103.0% | 12.0% | −163.0% | −145.0% | −42.0% | −1,122.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 151 | 160 | 174 | 195 | 140 | 131 | 125 | 154 | 127 | 129 | 96 | 88 |
| Inventory days | 394 | 433 | 538 | 593 | 613 | 380 | 435 | 438 | 490 | 456 | 302 | 470 |
| Days payable | 235 | 266 | 402 | 411 | 329 | 198 | 312 | 350 | 336 | 337 | 386 | 395 |
| Cash conversion cycle | 308 | 325 | 307 | 375 | 420 | 311 | 246 | 239 | 277 | 245 | 8 | 160 |
| Working capital days | 64 | 97 | 63 | 72 | 109 | 86 | 73 | 91 | 51 | −44 | −139 | −53 |
| ROCE % | 26.1% | 17.0% | 21.0% | 20.0% | 11.1% | −5.0% | 13.0% | 9.0% | −5.0% | −13.9% | −7.0% | 5.0% |
For the Jun 2026 quarter, JK Agri Genetics reported sales of ₹83.97 Cr, down 8.7% year on year and net profit of ₹11.01 Cr, down 8.3% year on year. The operating margin was 17.9%.
JK Agri Genetics' sales for the year to Mar 2026 were ₹158 Cr; over the last twelve months they were ₹150 Cr.
Net profit for the year to Mar 2026 was −₹7.01 Cr, and −₹8.02 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−18.51.
JK Agri Genetics reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹1.01 Cr.
Cash from operations was −₹27.91 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹29.12 Cr.